BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

618 related articles for article (PubMed ID: 26269457)

  • 1. O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice.
    Makino A; Dai A; Han Y; Youssef KD; Wang W; Donthamsetty R; Scott BT; Wang H; Dillmann WH
    Am J Physiol Cell Physiol; 2015 Nov; 309(9):C593-9. PubMed ID: 26269457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. O-GlcNAcylation of connexin 40: a sweet connection between diabetes and endothelial cell dysfunction? Focus on "O-GlcNAcase overexpression reverses coronary endothelial cell dysfunction in type 1 diabetic mice".
    Issad T
    Am J Physiol Cell Physiol; 2015 Nov; 309(9):C590-2. PubMed ID: 26377315
    [No Abstract]   [Full Text] [Related]  

  • 3. Fine-tuning the cardiac O-GlcNAcylation regulatory enzymes governs the functional and structural phenotype of the diabetic heart.
    Prakoso D; Lim SY; Erickson JR; Wallace RS; Lees JG; Tate M; Kiriazis H; Donner DG; Henstridge DC; Davey JR; Qian H; Deo M; Parry LJ; Davidoff AJ; Gregorevic P; Chatham JC; De Blasio MJ; Ritchie RH
    Cardiovasc Res; 2022 Jan; 118(1):212-225. PubMed ID: 33576380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of p53 due to excess protein O-GlcNAcylation is associated with coronary microvascular disease in type 2 diabetes.
    Si R; Zhang Q; Tsuji-Hosokawa A; Watanabe M; Willson C; Lai N; Wang J; Dai A; Scott BT; Dillmann WH; Yuan JX; Makino A
    Cardiovasc Res; 2020 May; 116(6):1186-1198. PubMed ID: 31504245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. E2F1 Transcription Factor Regulates O-linked N-acetylglucosamine (O-GlcNAc) Transferase and O-GlcNAcase Expression.
    Muthusamy S; Hong KU; Dassanayaka S; Hamid T; Jones SP
    J Biol Chem; 2015 Dec; 290(52):31013-24. PubMed ID: 26527687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging roles of protein O-GlcNAcylation in cardiovascular diseases: Insights and novel therapeutic targets.
    Bolanle IO; Riches-Suman K; Williamson R; Palmer TM
    Pharmacol Res; 2021 Mar; 165():105467. PubMed ID: 33515704
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of hexokinase 2 reduces mitochondrial calcium overload in coronary endothelial cells of type 2 diabetic mice.
    Pan M; Han Y; Basu A; Dai A; Si R; Willson C; Balistrieri A; Scott BT; Makino A
    Am J Physiol Cell Physiol; 2018 Jun; 314(6):C732-C740. PubMed ID: 29513568
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in O-Linked N-Acetylglucosamine (O-GlcNAc) Homeostasis Activate the p53 Pathway in Ovarian Cancer Cells.
    de Queiroz RM; Madan R; Chien J; Dias WB; Slawson C
    J Biol Chem; 2016 Sep; 291(36):18897-914. PubMed ID: 27402830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hijacking of the O-GlcNAcZYME complex by the HTLV-1 Tax oncoprotein facilitates viral transcription.
    Groussaud D; Khair M; Tollenaere AI; Waast L; Kuo MS; Mangeney M; Martella C; Fardini Y; Coste S; Souidi M; Benit L; Pique C; Issad T
    PLoS Pathog; 2017 Jul; 13(7):e1006518. PubMed ID: 28742148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feedback Regulation of
    Lin CH; Liao CC; Chen MY; Chou TY
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33801653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. E2f1 deletion attenuates infarct-induced ventricular remodeling without affecting O-GlcNAcylation.
    Dassanayaka S; Brittian KR; Jurkovic A; Higgins LA; Audam TN; Long BW; Harrison LT; Militello G; Riggs DW; Chitre MG; Uchida S; Muthusamy S; Gumpert AM; Jones SP
    Basic Res Cardiol; 2019 May; 114(4):28. PubMed ID: 31152247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. O-GlcNAcylation of RBM14 contributes to elevated cellular O-GlcNAc through regulation of OGA protein stability.
    Kweon TH; Jung H; Ko JY; Kang J; Kim W; Kim Y; Kim HB; Yi EC; Ku NO; Cho JW; Yang WH
    Cell Rep; 2024 May; 43(5):114163. PubMed ID: 38678556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restoration of coronary microvascular function by OGA overexpression in a high-fat diet with low-dose streptozotocin-induced type 2 diabetic mice.
    Cabrera JT; Si R; Tsuji-Hosokawa A; Cai H; Yuan JX; Dillmann WH; Makino A
    Diab Vasc Dis Res; 2023; 20(3):14791641231173630. PubMed ID: 37186669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of O-linked N-acetylglucosamine modification in diabetic nephropathy.
    Gellai R; Hodrea J; Lenart L; Hosszu A; Koszegi S; Balogh D; Ver A; Banki NF; Fulop N; Molnar A; Wagner L; Vannay A; Szabo AJ; Fekete A
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1172-F1181. PubMed ID: 27029430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence of a compensatory regulation of colonic O-GlcNAc transferase and O-GlcNAcase expression in response to disruption of O-GlcNAc homeostasis.
    Decourcelle A; Loison I; Baldini S; Leprince D; Dehennaut V
    Biochem Biophys Res Commun; 2020 Jan; 521(1):125-130. PubMed ID: 31630803
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yeast cells as an assay system for in vivo O-GlcNAc modification.
    Nakanishi H; Li F; Han B; Arai S; Gao XD
    Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1159-1167. PubMed ID: 28263870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adenovirus-mediated overexpression of O-GlcNAcase improves contractile function in the diabetic heart.
    Hu Y; Belke D; Suarez J; Swanson E; Clark R; Hoshijima M; Dillmann WH
    Circ Res; 2005 May; 96(9):1006-13. PubMed ID: 15817886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. O-GlcNAc cycling enzymes control vascular development of the placenta by modulating the levels of HIF-1α.
    Yang YR; Jang HJ; Lee YH; Kim IS; Lee H; Ryu SH; Suh PG
    Placenta; 2015 Oct; 36(10):1063-8. PubMed ID: 26286378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy decreases O-GlcNAc-modified proteins in systemic arteries of normotensive and spontaneously hypertensive rats.
    Troiano JA; Potje SR; Graton ME; Silva DS; da Costa RM; Tostes RC; Antoniali C
    Life Sci; 2021 Feb; 266():118885. PubMed ID: 33316265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OGT and OGA expression in postmenopausal skeletal muscle associates with hormone replacement therapy and muscle cross-sectional area.
    Toivonen MH; Pöllänen E; Ahtiainen M; Suominen H; Taaffe DR; Cheng S; Takala T; Kujala UM; Tammi MI; Sipilä S; Kovanen V
    Exp Gerontol; 2013 Dec; 48(12):1501-4. PubMed ID: 24365779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.